logo-loader
viewPetVivo Holdings Inc.

PetVivo Holdings switches from treating humans to horses

PetVivo Holdings Inc (OTCMKTS:PETV) President John Lai tells Proactive Investors how the two-decade-old company went from treating humans to horses.

The biomedical device company developed degenerative medicine for humans for over 15 years before switching to veterinary medicine.

Around two weeks ago, the company introduced an injectable treatment for osteoarthritis in horses and dogs called Kush.

The Minneapolis-based company has plans to uplist to the Nasdaq within the next 12 months.

Quick facts: PetVivo Holdings Inc.

Price: 0.35 USD

OTCMKTS:PETV
Market: OTCQB
Market Cap: $7.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Perseus Mining reports 'minimal impact' from coronavirus but is well placed...

Perseus Mining Limited's (ASX:PRU) Jeff Quartermaine talks Proactive's Andrew Scott through their planning for COVID-19 and how they're 'well-positioned' to deal with the outbreak.  He says they're adapting its activities around the current pandemic using systems developed during the...

2 days, 8 hours ago

2 min read